ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,179.94
0.95%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Capstone Therapeutics Corporation (QB) (CAPS)

  7. Capstone Therapeutics Corporation (QB) (CAPS) News

Capstone Therapeutics (QB) (CAPS)

Capstone Therapeutics Corporation (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:CAPS
DateTimeSourceHeadlineSymbolCompany
25/09/201921:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
09/09/201914:02Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
26/08/201921:00Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
20/08/201922:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/08/201914:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
10/07/201921:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
03/07/201919:52Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
03/07/201919:41Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
31/05/201921:48Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)USOTC:CAPSCapstone Therapeutics Corporation (QB)
31/05/201921:04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/05/201917:03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
22/03/201920:04Edgar (US Regulatory)Annual Report (10-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
21/03/201913:03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
21/03/201913:03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
21/03/201913:03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
21/03/201913:02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
19/03/201921:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
19/03/201920:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/02/201921:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
11/02/201918:02Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
04/02/201920:53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CAPSCapstone Therapeutics Corporation (QB)
28/12/201817:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CAPSCapstone Therapeutics Corporation (QB)
20/11/201822:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
06/11/201820:33Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/08/201821:04Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
18/05/201822:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
11/05/201821:03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
07/05/201814:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
28/02/201821:04Edgar (US Regulatory)Annual Report (10-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
01/02/201823:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CAPSCapstone Therapeutics Corporation (QB)
 Showing the most relevant articles for your search:USOTC:CAPS

Your Recent History

LSE
NG.
National Grid
LSE
POS
Plexus
LSE
ENET
Ethernity Networks
LSE
SRSP
Sirius Petroleum
LSE
SCLP
Scancell
LSE
VAST
Vast Resources
LSE
ZED
Zenova
LSE
LLOY
Lloyds Banking
LSE
AVCT
Avacta
LSE
CHLL
Chill Brands
LSE
NFDS
Northern Foods
LSE
TERN
Tern
LSE
AGL
Angle
LSE
SOS
Sosandar
LSE
KRS
Keras Resources
LSE
VLX
Volex
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved